Prellis Biologics
Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics' technology leverages massive gains in print speed and resolution to break the microvasculature barrier. The company was founded in 2016 and is based in San Francisco, California.
Tech Stack (12 technologies)
Frequently Asked Questions
What technologies does Prellis Biologics use?+
Prellis Biologics uses 12 technologies including Google Tag Manager, Next.js, GSAP.
What industry is Prellis Biologics in?+
Prellis Biologics operates in the 3D Printing industry.
Where is Prellis Biologics based?+
Prellis Biologics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026